CL2018001612A1 - Método de terapia fotodinámica (pdt) para el cáncer de vejiga - Google Patents

Método de terapia fotodinámica (pdt) para el cáncer de vejiga

Info

Publication number
CL2018001612A1
CL2018001612A1 CL2018001612A CL2018001612A CL2018001612A1 CL 2018001612 A1 CL2018001612 A1 CL 2018001612A1 CL 2018001612 A CL2018001612 A CL 2018001612A CL 2018001612 A CL2018001612 A CL 2018001612A CL 2018001612 A1 CL2018001612 A1 CL 2018001612A1
Authority
CL
Chile
Prior art keywords
bladder cancer
photodynamic therapy
pdt
therapy method
composition
Prior art date
Application number
CL2018001612A
Other languages
English (en)
Spanish (es)
Inventor
Kjetil Hestdal
Aslak Godal
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of CL2018001612A1 publication Critical patent/CL2018001612A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/307—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the urinary organs, e.g. urethroscopes or cystoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/061—Bladder and/or urethra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CL2018001612A 2015-12-17 2018-06-14 Método de terapia fotodinámica (pdt) para el cáncer de vejiga CL2018001612A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15200938 2015-12-17

Publications (1)

Publication Number Publication Date
CL2018001612A1 true CL2018001612A1 (es) 2019-01-11

Family

ID=55066354

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018001612A CL2018001612A1 (es) 2015-12-17 2018-06-14 Método de terapia fotodinámica (pdt) para el cáncer de vejiga

Country Status (18)

Country Link
US (2) US11235168B2 (enExample)
EP (1) EP3389716B1 (enExample)
JP (1) JP6995755B2 (enExample)
KR (1) KR102787192B1 (enExample)
CN (2) CN119345612A (enExample)
AU (1) AU2016372575B2 (enExample)
BR (1) BR112018011965A2 (enExample)
CA (1) CA3008552C (enExample)
CL (1) CL2018001612A1 (enExample)
DK (1) DK3389716T3 (enExample)
ES (1) ES2910034T3 (enExample)
IL (1) IL259925B (enExample)
MX (1) MX385912B (enExample)
PL (1) PL3389716T3 (enExample)
RU (1) RU2745194C2 (enExample)
SG (1) SG11201805000RA (enExample)
WO (1) WO2017103285A1 (enExample)
ZA (1) ZA201804530B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3389716B1 (en) * 2015-12-17 2022-03-23 Photocure ASA Method of photodynamic therapy (pdt) for bladder cancer
CN110420326A (zh) * 2019-09-17 2019-11-08 上海复旦张江生物医药股份有限公司 一种多替泊芬的应用
KR20240011794A (ko) * 2021-08-17 2024-01-26 보스톤 싸이엔티픽 싸이메드 인코포레이티드 광활성제의 활성화를 위한 디바이스, 시스템 및 방법
KR20250154511A (ko) 2023-03-07 2025-10-28 포토큐어 에이에스에이 방광암 치료
WO2026052815A1 (en) 2024-09-05 2026-03-12 Photocure Asa Use of hal in a method for predicting bladder cancer immunotherapy response

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122006000051I1 (de) 1995-03-10 2007-01-04 Photocure Asa Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US20050003154A1 (en) * 2002-12-13 2005-01-06 White Gary L. Laminated building panels having preselected colors
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
CN101891639A (zh) 2009-05-20 2010-11-24 上海先导化学有限公司 一种制备5-氨基酮戊酸盐酸盐的方法
AU2010257752B2 (en) 2009-06-11 2015-04-09 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
WO2010142457A1 (en) 2009-06-11 2010-12-16 Photocure Asa Semi-solid compositions and pharmaceutical products
RU2448745C2 (ru) * 2010-05-31 2012-04-27 Олег Феликсович Каган Способ лечения поверхностного рака мочевого пузыря
US20150088001A1 (en) 2011-12-19 2015-03-26 Technical University Of Denmark Illumination System for Endoscopic Applications
RU2635563C2 (ru) * 2012-08-03 2017-11-14 ФотоКьюэр АСА Соединения
GB201221123D0 (en) * 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
EP3389716B1 (en) * 2015-12-17 2022-03-23 Photocure ASA Method of photodynamic therapy (pdt) for bladder cancer

Also Published As

Publication number Publication date
US11235168B2 (en) 2022-02-01
RU2745194C2 (ru) 2021-03-22
AU2016372575A1 (en) 2018-07-12
CA3008552A1 (en) 2017-06-22
DK3389716T3 (da) 2022-04-11
MX385912B (es) 2025-03-18
ES2910034T3 (es) 2022-05-11
IL259925A (en) 2018-07-31
CN119345612A (zh) 2025-01-24
KR102787192B1 (ko) 2025-03-25
KR20180094986A (ko) 2018-08-24
PL3389716T3 (pl) 2022-06-20
AU2016372575B2 (en) 2022-12-08
EP3389716A1 (en) 2018-10-24
JP2019501161A (ja) 2019-01-17
NZ743697A (en) 2024-10-25
ZA201804530B (en) 2019-09-25
EP3389716B1 (en) 2022-03-23
RU2018123834A3 (enExample) 2020-04-13
US11980772B2 (en) 2024-05-14
JP6995755B2 (ja) 2022-01-17
SG11201805000RA (en) 2018-07-30
BR112018011965A2 (pt) 2018-12-04
US20220152411A1 (en) 2022-05-19
RU2018123834A (ru) 2020-01-17
CA3008552C (en) 2024-01-02
WO2017103285A1 (en) 2017-06-22
US20190022404A1 (en) 2019-01-24
CN108697800A (zh) 2018-10-23
IL259925B (en) 2022-04-01

Similar Documents

Publication Publication Date Title
CL2020000299A1 (es) Compuestos, composiciones y métodos.
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
EA201691866A1 (ru) Проникающие в опухоль лимфоциты для адоптивной клеточной терапии
AR102553A1 (es) Terapia de combinación con agonistas de unión ox40 e inhibidores de tigit
CL2016002027A1 (es) Ciclopropilamina como inhibidor de la lsd1
MX2019007276A (es) Composiciones y métodos para mejora o aumento de la producción de ifn tipo i.
CL2018003123A1 (es) Terapia de combinación para el tratamiento del cáncer
CR20190350A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
AR106582A1 (es) Formulaciones subcutáneas de anticuerpos anti-cd38 y sus usos
EA201591674A1 (ru) Противораковые вакцины и способы лечения с их применением
MX2016007328A (es) Suministro, uso y aplicaciones terapeuticas de sistemas y composiciones crispr-cas para edicion del genoma.
MX2015017312A (es) Suministro y uso de composiciones, vectores y sistemas crispr-cas para la modificación dirigida y terapia hepáticas.
ECSP18096095A (es) Anticuerpos a la alfa-sinucleína y usos de los mismos
CR20200334A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
CL2017000290A1 (es) Inhibidores de la proteína kinasa c y métodos de su uso.
MX2017016681A (es) Uso de compuestos de cloroquina y clemizol para el tratamiento de afecciones inflamatorias y cancerosas.
MX383484B (es) Método para tratar el cáncer.
MX2016004441A (es) Tratamiento del cancer con una combinacion de plinabulina y taxano.
CR20180228A (es) Terapia adjunta con 25-hidroxi vitamina d y articulos de la misma
CL2017000317A1 (es) Terapia adjuntiva con 25-hidroxi vitamina d
CL2018002793A1 (es) Terapia de cáncer con un virus oncolítico combinado con un inhibidor de puntos de control
CO2020001107A2 (es) Moduladores terapéuticos del modo inverso de la atp sintasa
AR112102A1 (es) Tinostamustina para utilizar en el tratamiento de cáncer de ovario
AR112144A1 (es) Compuestos para el tratamiento del sarcoma
MX386249B (es) Terapia tusc2 para usarse en el tratamiento de cáncer.